Balloon pulmonary angioplasty in inoperable chronic thromboembolic pulmonary hypertension. Issue 4 (4th April 2022)

• Record Type: Journal Article
• Authors: Pereira, Ana Rita; Calé, Rita; Ferreira, Filipa; Pereira, Helder
• Is Part Of: BMJ case reports. Volume 15:Issue 4(2022)
• Publication Date: 2022-04-04
• Subjects: pulmonary embolism -- pulmonary hypertension -- interventional cardiology -- interventional radiology; Medicine -- Case studies -- Periodicals; 610.5
• DOI: 10.1136/bcr-2021-247318
• Languages: English
• ISSNs: 1757-790X

Abstract

Abstract : Balloon pulmonary angioplasty (BPA) is an emerging treatment for inoperable chronic thromboembolic pulmonary hypertension (CTEPH) or residual/recurrent pulmonary hypertension after pulmonary thromboendarterectomy. We report two patients with inoperable and severe CTEPH who were submitted to the BPA programme after optimised treatment with long-term oxygen therapy (LTOT) and pulmonary vasodilator drugs, including prostacyclin analogues. They experienced a significant improvement in exercise capacity, oxygenation, right ventricular function and pulmonary haemodynamics. This improvement allowed withdrawal from LTOT and prostacyclin analogues therapies and, consequently, improved patients' quality of life and reduced future health-related costs. The reported clinical cases intend to highlight the effectiveness of BPA in patients with inoperable CTEPH for whom the only available therapy was, until recently, the pulmonary vasodilator drugs.